Author

R. Aljumaily

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Antibody-drug conjugate–associated pneumonitis (AAP) across novel first-in-human phase I trials: A pooled single-center analysis.

524 Background: Antibody-drug conjugates (ADCs) are increasingly used in cancer care; toxicities like Antibody-Drug Conjugate Associated Pneumonitis (AAP) have emerged as clinically significant & fatal adverse events. Data characterizing AAP across phase 1 trials is limited. Methods: We retrospectively collec...

Falah Fayaz, A. Aijaz, Hassan M. Abushukair et al. · JCO Oncology Practice · 0 citations

Review Open access Sep 2026

Clinical and genomic characterization of KRAS G13X non-small cell lung carcinoma

KRAS G13X mutations represent a small but clinically meaningful subset of NSCLC defined by a distinctive co-mutation pattern and Combinational therapeutic strategies addressing these vulnerabilities can help improve outcomes.

Benjamin J. Staum, Rachaita Lakra, A. Ravindra et al. · Frontiers in Oncology · 0 citations